Chison Medical Technologies Co., Ltd. (SHA:688358)

SHA:688358 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	115.77	116.5	140.51	146.48	105.84	112.47
Depreciation & Amortization	13.6	13.6	14.78	14.26	13.03	9.89
Other Amortization	0.89	0.89	0.26	0.04	0.13	0.24
Loss (Gain) From Sale of Assets	-4.53	-4.53	-4.61	-3.02	0.5	-30.25
Asset Writedown & Restructuring Costs	-	-	-	0.06	0.51	1.58
Loss (Gain) From Sale of Investments	-3.43	-3.43	-6.29	-11.17	-15	-17.53
Provision & Write-off of Bad Debts	1.47	1.47	1.7	3.58	-1.4	0.74
Other Operating Activities	-4.16	16.11	-16.92	-19.06	-15.19	6.22
Change in Accounts Receivable	-35.68	-35.68	-1.01	-78.87	37.02	-1.55
Change in Inventory	-7.03	-7.03	5.65	56.08	-100.41	-16.76
Change in Accounts Payable	12.05	12.05	7.83	-20.33	41.92	-25.33
Change in Other Net Operating Assets	-0.06	-0.06	-2.03	-2.92	-0.82	1.37
Operating Cash Flow	86.17	107.17	140.68	85.91	63.74	39.96
Operating Cash Flow Growth	-39.89%	-23.82%	63.76%	34.78%	59.51%	-51.53%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-20.55	-14.41	-8.85	-34.01	-52.21	-39.19
Sale of Property, Plant & Equipment	2.7	5.57	5.01	3.71	0.09	21.17
Investment in Securities	80.41	57.16	535.7	-236.03	-	165
Other Investing Activities	5.8	9.5	23.68	25.15	6.69	17.1
Investing Cash Flow	68.36	57.82	555.53	-241.18	-45.43	164.09

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Repaid	-	-4.4	-4.3	-0.95	-0.93	-0.61
Lease Payments	-4.4	-4.4	-4.3	-0.95	-0.93	-0.61
Net Debt Issued (Repaid)	-4.4	-4.4	-4.3	-0.95	-0.93	-0.61
Issuance of Common Stock	3.74	3.74	-	-	2.02	-
Repurchase of Common Stock	-	-	-	-10.1	-	-
Common Dividends Paid	-53.2	-111.87	-89.5	-78.49	-40	-64
Other Financing Activities	2.17	-	-	-	-	-
Financing Cash Flow	-51.69	-112.54	-93.8	-89.53	-38.91	-64.61

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-54.38	-30.54	12.24	9.34	21.59	-2.99
Net Cash Flow	48.46	21.91	614.64	-235.47	0.99	136.45

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	65.62	92.76	131.83	51.9	11.53	0.78
Free Cash Flow Growth	-49.43%	-29.64%	154.02%	350.04%	1386.91%	-98.50%
Free Cash Flow Margin	14.79%	21.29%	28.13%	10.73%	3.03%	0.19%
Free Cash Flow Per Share	0.58	0.83	1.18	0.47	0.10	0.01
Levered Free Cash Flow	66.95	53.66	105.05	-2.85	-16.31	5.74
Unlevered Free Cash Flow	67.18	53.86	105.28	-2.63	-16.24	5.78
Free Cash Flow After Leases	61.22	88.36	127.53	50.95	10.61	0.16

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Income Tax Paid	-	-7.52	-2.42	0.48	-6.43	-14.31
Change in Working Capital	-33.45	-33.45	11.26	-45.26	-24.68	-43.4

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error